International Patent: MULTISPECIFIC ANTIBODIES TARGETING EGFR AND CLEC5A AND THE USES THEREOF

GENEVA, July 18 -- LTZ THERAPEUTICS INC. filed a patent application (US2026/010767) for “MULTISPECIFIC ANTIBODIES TARGETING EGFR AND CLEC5A AND THE USES THEREOF”. With publication no. WO/2026/151977, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....